コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 rticle, we demonstrate that the nonclassical peroxisome proliferator 4-phenyl butyric acid is an effi
2 essed the hypothesis that variability in the Peroxisome Proliferator Activated Receptor (PPAR) pathwa
3 1) in aged Paneth cells inhibits activity of peroxisome proliferator activated receptor alpha (PPAR-a
4 e glutathione-S-transferase 4-4 (Gsta4(-/-))/peroxisome proliferator activated receptor alpha (Ppara(
5 esponsive element binding protein 1 (CREB1), peroxisome proliferator activated receptor alpha (PPARA)
7 f human chorionic gonadotropin (hCGbeta) and peroxisome proliferator activated receptor gamma (PPARga
8 chain amino acids (BCAA), and regulation of peroxisome proliferator activated receptor gamma (PPARga
9 ty to activate the nuclear hormone receptor, peroxisome proliferator activated receptor gamma (PPARga
11 TZDs) target the transcriptional activity of peroxisome proliferator activated receptor gamma (PPARga
13 e dismutase, mitochondrial KATP channels and peroxisome proliferator activated receptor gamma coactiv
15 ect of PERC on bodyweight loss, induction of peroxisome proliferator activated receptor-alpha (PPARal
16 ificant alterations in pathways regulated by peroxisome proliferator activated receptor-gamma (PPARga
17 through suppression of hepatic expression of peroxisome proliferator activated receptor-gamma and gen
18 pression of the steatogenic nuclear receptor peroxisome proliferator-activated gamma (PPARgamma) and
19 involved in the steatogenic nuclear receptor peroxisome proliferator-activated gamma (PPARgamma) path
22 We hypothesized that bezafibrate, a broad peroxisome proliferator-activated receptor (PPAR) agonis
25 ption factors farnesoid X receptor (FXR) and peroxisome proliferator-activated receptor (PPAR) delta
27 bound by the adipocytic transcription factor peroxisome proliferator-activated receptor (PPAR) gamma,
28 of SOD2 (superoxide dismutase 2), PGC1alpha [peroxisome proliferator-activated receptor (PPAR) gamma-
29 s, we identify circulating factors involving peroxisome proliferator-activated receptor (PPAR) pathwa
30 d mothers against decapentaplegic homologs), peroxisome proliferator-activated receptor (PPAR), and P
31 a models, we report that CD8(+) TILs enhance peroxisome proliferator-activated receptor (PPAR)-alpha
33 etion from hepatocytes in vivo downregulated peroxisome proliferator-activated receptor (PPAR)-alpha,
34 nt receptor potential vanilloid (TRPV)-1 and peroxisome proliferator-activated receptor (PPAR)-alpha.
36 ipogenesis (+30% Oil Red O stain [ORO], +50% peroxisome proliferator-activated receptor (PPAR)-gamma
38 chanistic target of rapamycin (mTOR) and the peroxisome proliferator-activated receptor (PPAR)-gamma
39 latter case, this involves up-regulation of peroxisome proliferator-activated receptor (PPAR)alpha e
40 , dipeptidyl peptidase 4 (DPP-4) inhibitors, peroxisome proliferator-activated receptor (PPAR-gamma/a
41 of genes related to fatty acid synthesis and peroxisome proliferator-activated receptor (PPARalpha) s
42 into lipid-laden adipocytes by upregulating peroxisome proliferator-activated receptor (PPARgamma) a
43 o the arylhydrocarbon receptor (AhR) and the peroxisome proliferator-activated receptor (PPARgamma);
44 to a putatively advantageous allele for the peroxisome proliferator-activated receptor A (PPARA) gen
46 pression was enhanced by insulin-sensitizing peroxisome proliferator-activated receptor agonists and
47 receptor type 1 (CB1) or type 2 (CB2) or via peroxisome proliferator-activated receptor alpha (PPAR-a
48 adipocytes by controlling the expression of peroxisome proliferator-activated receptor alpha (Ppara)
49 (TGF-beta)-regulated phospho-Akt (p-Akt) and peroxisome proliferator-activated receptor alpha (PPARal
50 iptome analysis identifies the lipid-sensing peroxisome proliferator-activated receptor alpha (PPARal
51 arnitine palmitoyltransferase 1A (CPT1A) and peroxisome proliferator-activated receptor alpha (PPARal
52 arvation, CREBH regulates and interacts with peroxisome proliferator-activated receptor alpha (PPARal
54 n, Acot1 knockdown reduced the expression of peroxisome proliferator-activated receptor alpha (PPARal
55 hepatic AMP-activated protein kinase (AMPK), peroxisome proliferator-activated receptor alpha (PPARal
57 and stabilizes the ligand-binding domain of peroxisome proliferator-activated receptor alpha (PPARal
59 igated whether Astragaloside IV can activate peroxisome proliferator-activated receptor alpha (PPARal
60 such as bezafibrate, known activators of the peroxisome proliferator-activated receptor alpha (PPARal
61 ific DRE that overlaps binding sequences for peroxisome proliferator-activated receptor alpha (PPARal
62 or the nuclear receptor transcription factor peroxisome proliferator-activated receptor alpha (PPARal
63 activation of transcription factors such as peroxisome proliferator-activated receptor alpha (PPARal
64 sed expression were known to be regulated by peroxisome proliferator-activated receptor alpha (PPARal
65 fasting, activation of the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARal
66 dy was to investigate the protective role of peroxisome proliferator-activated receptor alpha (PPARal
69 ansforming growth factor beta (TGF-beta) and peroxisome proliferator-activated receptor alpha (PPARal
70 ation, due to a reduced abundance of mRNA of peroxisome proliferator-activated receptor alpha (PPARal
72 ecular analysis unraveled that inhibition of peroxisome proliferator-activated receptor alpha activit
73 ardiac lipotoxicity, and discuss the role of peroxisome proliferator-activated receptor alpha and dys
74 ated by several nuclear receptors, including peroxisome proliferator-activated receptor alpha and/or
75 omatin immunoprecipitation assays identified peroxisome proliferator-activated receptor alpha as a me
76 nvolved in fatty acid beta-oxidation through peroxisome proliferator-activated receptor alpha phospho
77 gene is an AMP-activated protein kinase and peroxisome proliferator-activated receptor alpha respons
78 Falpha (3.0-fold), whereas the expression of peroxisome proliferator-activated receptor alpha target
80 anscription factors, particularly PPARalpha (peroxisome proliferator-activated receptor alpha), and l
81 to the increased transcriptional activity of peroxisome proliferator-activated receptor alpha, the tr
82 ment binding protein-hepatocyte specific and peroxisome proliferator-activated receptor alpha, which
85 for the farnesoid X receptor (FXR) and dual peroxisome proliferator-activated receptor alpha/delta (
86 or-activated receptor-alpha (PPARalpha), and peroxisome proliferator-activated receptor beta/delta (P
94 Moreover, FAs from higher lipolysis activate peroxisome proliferator-activated receptor delta to indu
95 with markedly diminished ability to activate peroxisome proliferator-activated receptor gamma (MSDC-0
96 We studied interactions between polar bear peroxisome proliferator-activated receptor gamma (pbPPAR
99 ng through the intracellular butyrate sensor peroxisome proliferator-activated receptor gamma (PPAR-g
100 CL10 and IL-6 transcript levels, and induced peroxisome proliferator-activated receptor gamma (PPAR-g
101 action between OmpA and Ecgp96 downregulates peroxisome proliferator-activated receptor gamma (PPAR-g
103 homeostasis, epithelial hypoxia derived from peroxisome proliferator-activated receptor gamma (PPAR-g
105 ified ETS translocation variant 4 (ETV4) and peroxisome proliferator-activated receptor gamma (PPARG)
106 on of several of its target genes, including peroxisome proliferator-activated receptor gamma (PPARG)
107 alus) and blue whale (Balaenoptera musculus) peroxisome proliferator-activated receptor gamma (PPARG)
108 een in a Pten-null background, we identified peroxisome proliferator-activated receptor gamma (Pparg)
109 he HFCF diet, WT mice displayed up-regulated peroxisome proliferator-activated receptor gamma (Pparg)
111 hat binds and activates the nuclear receptor peroxisome proliferator-activated receptor gamma (PPARga
112 d structures of nuclear receptors, including peroxisome proliferator-activated receptor gamma (PPARga
113 conformational ensemble of nuclear receptor peroxisome proliferator-activated receptor gamma (PPARga
114 to stimulate or inhibit the activity of the peroxisome proliferator-activated receptor gamma (PPARga
116 pha), C/EBPbeta, C/EBPdelta, KLF5, KLF9, and peroxisome proliferator-activated receptor gamma (PPARga
117 their direct action on the nuclear receptor peroxisome proliferator-activated receptor gamma (PPARga
118 ich was recruited to the promoter of Nox1, a peroxisome proliferator-activated receptor gamma (PPARga
119 iated macrophage differentiation by cleaving peroxisome proliferator-activated receptor gamma (PPARga
120 tion depends on interactions between Sp1 and peroxisome proliferator-activated receptor gamma (PPARga
121 y isoflavone genistein, a natural agonist of peroxisome proliferator-activated receptor gamma (PPARga
123 miR-503 expression is directly regulated by peroxisome proliferator-activated receptor gamma (PPARga
124 und that this defect is because of defective peroxisome proliferator-activated receptor gamma (PPARga
129 ancer-binding protein alpha (C/EBPalpha) and peroxisome proliferator-activated receptor gamma (PPARga
133 d the extracellular matrix, particularly the peroxisome proliferator-activated receptor gamma (Pparga
135 We report direct activation of the nuclear peroxisome proliferator-activated receptor gamma (PPARga
136 lipid droplet formation and the induction of peroxisome proliferator-activated receptor gamma (PPARga
137 gh levels of TNF and IL-12 but low levels of peroxisome proliferator-activated receptor gamma (PPARga
138 anoparticle (NP) platforms to deliver either Peroxisome Proliferator-Activated Receptor gamma (PPARga
140 n of master adipogenic transcription factors peroxisome proliferator-activated receptor gamma (PPARga
142 duction of prostaglandin J2 (PGJ2) activates peroxisome proliferator-activated receptor gamma (PPARga
143 ere, we tested this hypothesis on three NRs: peroxisome proliferator-activated receptor gamma (PPARga
144 und 3a that possesses weak proadipogenic and peroxisome proliferator-activated receptor gamma (PPARga
145 ow GIP-R expression can be regulated through peroxisome proliferator-activated receptor gamma (PPARga
146 nd profiling of photoswitchable agonists for peroxisome proliferator-activated receptor gamma (PPARga
147 pid metabolism genes during NAFLD, including peroxisome proliferator-activated receptor gamma (PPARga
148 -depleted mice, and conditional OPC-specific peroxisome proliferator-activated receptor gamma (PPARga
149 ot BCRP transport activity were blocked by a peroxisome proliferator-activated receptor gamma (PPARga
150 /enhancer-binding protein family members and peroxisome proliferator-activated receptor gamma (PPARga
152 ver development by suppressing expression of peroxisome proliferator-activated receptor gamma 2 and l
153 In LX-2 cells, FXR activation increased peroxisome proliferator-activated receptor gamma activit
154 ented the inflammatory response dependent on peroxisome proliferator-activated receptor gamma activit
155 N-terminal kinase inhibitor SP600125 and the peroxisome proliferator-activated receptor gamma agonist
156 , similar to TPHP, found that ciglitazone (a peroxisome proliferator-activated receptor gamma agonist
157 lated expression of the transcription factor peroxisome proliferator-activated receptor gamma and its
158 lta-prostaglandin J2-dependent activation of peroxisome proliferator-activated receptor gamma and mac
159 ated protein 2 expression and suppression of peroxisome proliferator-activated receptor gamma and p27
161 s, including uncoupling protein 1 (Ucp1) and peroxisome proliferator-activated receptor gamma co-acti
163 mitochondrial biogenesis regulatory protein peroxisome proliferator-activated receptor gamma coactiv
164 voluntary wheel running and muscle-specific peroxisome proliferator-activated receptor gamma coactiv
167 khead box transcription factors O (Foxo) and Peroxisome proliferator-activated receptor gamma coactiv
168 mitochondrial biogenesis, in particular via peroxisome proliferator-activated receptor gamma coactiv
169 e key regulator of mitochondrial biogenesis, peroxisome proliferator-activated receptor gamma coactiv
172 triggers complex adaptive responses in which peroxisome proliferator-activated receptor gamma coactiv
174 This coincided with decreased levels of peroxisome proliferator-activated receptor gamma coactiv
175 ssion, potentially through the regulation of peroxisome proliferator-activated receptor gamma coactiv
176 gnature genes uncoupling protein (UCP)-1 and peroxisome proliferator-activated receptor gamma coactiv
177 ouse, these UCP1(+) cells also expressed the peroxisome proliferator-activated receptor gamma coactiv
179 uction and ATP levels, reduced expression of peroxisome proliferator-activated receptor gamma coactiv
180 nd ZR75.1 breast cancer cells, IGF-1 induces peroxisome proliferator-activated receptor gamma coactiv
181 Here we demonstrate, unexpectedly, that peroxisome proliferator-activated receptor gamma coactiv
183 but was independent of the activation of the peroxisome proliferator-activated receptor gamma coactiv
184 e Huh7, the coexpression of the coactivators peroxisome proliferator-activated receptor gamma coactiv
185 city are known to regulate and interact with peroxisome proliferator-activated receptor gamma coactiv
186 Here we demonstrate that the coactivator peroxisome proliferator-activated receptor gamma coactiv
187 tably, the mitochondrial DNA copy number and peroxisome proliferator-activated receptor gamma coactiv
189 ation) and increased promoter methylation of peroxisome proliferator-activated receptor gamma coactiv
190 evels and the expression of four isoforms of peroxisome proliferator-activated receptor gamma coactiv
191 chondrial transcription factor A (TFAM), and peroxisome proliferator-activated receptor gamma coactiv
192 idrug resistance-associated protein 2 and 4, peroxisome proliferator-activated receptor gamma coactiv
193 ated the role of ERK1/2 on the expression of peroxisome proliferator-activated receptor gamma coactiv
194 mitochondrial respiration between legs, but peroxisome proliferator-activated receptor gamma coactiv
195 A subset of melanomas display heightened peroxisome proliferator-activated receptor gamma coactiv
196 sis (uncoupling protein-1, deiodinase-2, and peroxisome proliferator-activated receptor gamma coactiv
198 that fuses paired box gene 8 (PAX8) with the peroxisome proliferator-activated receptor gamma gene (P
200 nase 2, 15-deoxy Delta-prostaglandin J2, and peroxisome proliferator-activated receptor gamma in this
202 BPD that is not dependent on the decrease in peroxisome proliferator-activated receptor gamma levels.
203 or kappaB and NOS2, and an inhibition of the peroxisome proliferator-activated receptor gamma network
204 c-Jun N-terminal kinase, thereby inhibiting peroxisome proliferator-activated receptor gamma through
206 on of the glucose/lipid metabolism regulator peroxisome proliferator-activated receptor gamma was ass
207 m with 5-amino salicylic acid, a PPAR-gamma (peroxisome proliferator-activated receptor gamma) agonis
208 downstream transcription factors, PPARgamma (peroxisome proliferator-activated receptor gamma), and p
209 ammalian target of rapamycin or reactivating peroxisome proliferator-activated receptor gamma, an LAL
210 ing STAT3, STAT6, Kruppel-like factor 4, and peroxisome proliferator-activated receptor gamma, and ca
211 o the endoplasmic reticulum, down-regulating peroxisome proliferator-activated receptor gamma, and re
212 he mitochondrial transcriptional coactivator peroxisome proliferator-activated receptor gamma, coacti
213 nd import of the transcriptional coactivator peroxisome proliferator-activated receptor gamma-coactiv
214 e injections in rats were reported to induce peroxisome proliferator-activated receptor gamma-depende
215 gulating macrophage lipid metabolism through peroxisome proliferator-activated receptor gamma-depende
221 phosphatases, and ameliorated activation of peroxisome proliferator-activated receptor gamma/sterol
222 Tfe3, control the regulator of adipogenesis, peroxisome proliferator-activated receptor gamma2 (Pparg
223 protein-1 (MURF1)-mediated ubiquitylation of peroxisome proliferator-activated receptor gamma2 (PPARg
224 tein expressions of extracellular matrix and peroxisome proliferator-activated receptor pathways in s
225 of inflammatory mediators and repression of peroxisome proliferator-activated receptor signaling and
226 n metabolic pathways, some linked to altered peroxisome proliferator-activated receptor signaling, mu
227 the first week due to failure to undergo the peroxisome proliferator-activated receptor signaling-dep
228 ed attenuation of phagocytosis-induced PPAR (peroxisome proliferator-activated receptor) expression.
229 KLF5 (Kruppel-like factor-5) and PPARalpha (peroxisome proliferator-activated receptor) that regulat
230 h TGFbeta1 for receptor binding, while PPAR (peroxisome proliferator-activated receptor)-beta/delta a
232 (FoxO), AMP-activated protein kinase (AMPK), peroxisome proliferator-activated receptor-alpha (PPAR-a
233 palmitoylethanolamide (PEA), a lipid-derived peroxisome proliferator-activated receptor-alpha (PPAR-a
234 receptor-y coactivator 1-alpha (PGC-1alpha), peroxisome proliferator-activated receptor-alpha (PPARal
235 EA-m could be correlated at least in part to peroxisome proliferator-activated receptor-alpha activat
236 sepsis and to identify the mechanism whereby peroxisome proliferator-activated receptor-alpha confers
239 gulation of nhr-49 (an ortholog of the human peroxisome proliferator-activated receptor-alpha), and a
242 CD36 fine-tuned mitochondrial fitness via peroxisome proliferator-activated receptor-beta signalin
244 elpar is a potent, selective agonist for the peroxisome proliferator-activated receptor-delta (PPAR-d
245 growth hormone secretagogue ibutamoren, the peroxisome proliferator-activated receptor-delta agonist
246 wk with rosiglitazone, a specific agonist of peroxisome proliferator-activated receptor-gamma (PPAR-g
247 the upregulation of the transcription factor peroxisome proliferator-activated receptor-gamma (PPAR-g
249 d patients with NAFLD, hepatic expression of peroxisome proliferator-activated receptor-gamma (PPARG)
250 (TZD) antidiabetic drugs, which activate the peroxisome proliferator-activated receptor-gamma (PPARga
252 X receptors alpha and beta (LXRalpha,beta), peroxisome proliferator-activated receptor-gamma (PPARga
253 13.1 treatment were associated with enhanced peroxisome proliferator-activated receptor-gamma (PPARga
255 or (ER)-, glucocorticoid receptor (GR)-, and peroxisome proliferator-activated receptor-gamma (PPARga
259 ented and even partially reversed ex vivo by peroxisome proliferator-activated receptor-gamma agonist
261 a healthy human (mini-)organ, and show that peroxisome proliferator-activated receptor-gamma agonist
264 ion of mitochondrial biogenesis (PGC-1alpha [peroxisome proliferator-activated receptor-gamma coactiv
265 mediated by the transcriptional coactivator peroxisome proliferator-activated receptor-gamma coactiv
266 cal exercise and thyroid hormone mediate the peroxisome proliferator-activated receptor-gamma coactiv
267 lso show increased expression of PGC-1alpha (peroxisome proliferator-activated receptor-gamma coactiv
268 dismutase 2 (SOD2), and increased levels of peroxisome proliferator-activated receptor-gamma coactiv
269 a Silent information regulator 1 (SIRT1) and peroxisome proliferator-activated receptor-gamma coactiv
270 that 3-oxo-C12-HSL attenuates expression of peroxisome proliferator-activated receptor-gamma coactiv
271 EFs show increased expression of PGC-1alpha (peroxisome proliferator-activated receptor-gamma coactiv
272 (-/-) OPCs with cholesterol or activation of peroxisome proliferator-activated receptor-gamma with pi
273 ease of a transferable factor able to induce peroxisome proliferator-activated receptor-gamma-mediate
274 roxynonenal) released from the heart trigger peroxisome proliferator-activated receptor-gamma-mediate
275 (NFAT) and potentiated the transcription of peroxisome proliferator-activated receptor-y coactivator
276 s complex failed to alter, while blockade of peroxisome proliferator-activated receptors (PPARalpha,
279 he role of PPARgamma SIGNIFICANCE STATEMENT: Peroxisome proliferator-activated receptors (PPARs) are
281 tor families retinoid X receptors (RXRs) and peroxisome proliferator-activated receptors (PPARs) hold
285 iptionally repress FAO genes, antagonists of peroxisome proliferator-activated receptors (PPARs), par
286 NRs for treating metabolic diseases are the peroxisome proliferator-activated receptors (PPARs), PPA
289 th 14 other nuclear receptors, including the peroxisome proliferator-activated receptors (PPARs).
291 cumulation in the intestine and up-regulates peroxisome proliferator-activated receptors alpha and ga
293 ation of the estrogen, aryl hydrocarbon, and peroxisome proliferator-activated receptors; and oxidati
294 s study was to determine whether downstream [peroxisome proliferator-activated-receptor alpha (PPARal
295 al LPS exposure led to pre-existing elevated peroxisome proliferators-activated receptor-gamma co-act
296 ssues, including estrogen receptor alpha and peroxisome proliferator activator beta and gamma, indica
297 d suppression of systemic CCL2 production by peroxisome proliferator-activator receptor alpha (PPARal
298 otein [SREBP], acetyl-CoA carboxylase [ACC], peroxisome proliferator-activator receptors [PPARs], and
299 Computational analysis identified three peroxisome proliferator response elements (PPREs) within